Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity - USD ($)	Series A Convertible Preferred Stock	Common Stock ATM offering	Common Stock	Additional Paid-in capital ATM offering	Additional Paid-in capital	Accumulated other comprehensive loss	Accumulated deficit	ATM offering	Total
Equity, beginning balance at Dec. 31, 2020			$ 1,059		$ 231,438,483	$ (10,037,261)	$ (144,007,075)		$ 77,395,207
Equity, beginning balance (in shares) at Dec. 31, 2020			1,059,340
Increase (Decrease) in Stockholders' Equity
Issuance of common stock, net			$ 18		1,538,627				1,538,645
Issuance of common stock, net (in shares)			18,338
Exercise of stock options			$ 11		208,356				208,367
Exercise of stock options (in shares)			11,319
Vesting of restricted stock units			$ 4		(4)
Vesting of restricted stock units (in shares)			3,970
Stock-based compensation					7,813,743				7,813,743
Foreign currency translation						(321,695)			(321,695)
Net Income (Loss)							(37,127,303)		(37,127,303)
Equity, ending balance at Dec. 31, 2021			$ 1,092		240,999,206	(10,358,956)	(181,134,378)		49,506,964
Equity, ending balance (in shares) at Dec. 31, 2021			1,092,967
Increase (Decrease) in Temporary Equity
Issuance of preferred stock upon acquisition of Atrin	$ 68,777,468
Issuance of preferred stock upon acquisition of Atrin (in shares)	2,949,630
Conversion of preferred stock into common stock	$ (67,466,405)
Conversion of preferred stock into common stock (in shares)	(2,893,403)
Temporary equity, ending balance (in shares) at Dec. 31, 2022	56,227
Temporary equity, ending balance at Dec. 31, 2022	$ 1,311,063
Increase (Decrease) in Stockholders' Equity
Issuance of common stock, net			$ 39		682,934				682,973
Issuance of common stock, net (in shares)			38,481
Issuance of stock upon acquisition of Atrin			$ 56		1,329,643				1,329,699
Issuance of common stock upon acquisition of Atrin (in shares)			55,869
Value of assumed stock options					2,602,850				2,602,850
Vesting of restricted stock units			$ 21		(21)
Vesting of restricted stock units (in shares)			21,251
Stock-based compensation					16,981,266				16,981,266
Foreign currency translation						(264,452)			(264,452)
Conversion of preferred stock into common stock			$ 1,447		67,464,958				67,466,405
Conversion of preferred stock into common stock (in shares)			1,446,701
Net Income (Loss)							(112,662,027)		(112,662,027)
Equity, ending balance at Dec. 31, 2022			$ 2,655		330,060,836	(10,623,408)	(293,796,405)		25,643,678
Equity, ending balance (in shares) at Dec. 31, 2022			2,655,269
Temporary equity, ending balance (in shares) at Dec. 31, 2023	56,227
Temporary equity, ending balance at Dec. 31, 2023	$ 1,311,063
Increase (Decrease) in Stockholders' Equity
Issuance of common stock, net		$ 26	$ 1,050	$ 268,099	4,870,815			$ 268,125	4,871,865
Issuance of common stock, net (in shares)		26,302	1,050,000
Vesting of restricted stock units			$ 5		(5)
Vesting of restricted stock units (in shares)			5,102
Stock-based compensation					444,459				444,459
Foreign currency translation						12,135			12,135
Net Income (Loss)							(14,286,756)		(14,286,756)
Equity, ending balance at Dec. 31, 2023			$ 3,736		$ 335,644,204	$ (10,611,273)	$ (308,083,161)		$ 16,953,506
Equity, ending balance (in shares) at Dec. 31, 2023			3,736,673